EcoDrugPlus

Ribosomal Protein S5

Ensembl ID : ENSOMEG00000008257
Gene Symbol: RPS5
3 Cross references
264 Possible Orthologues:

Ribosomal Protein S7

Ensembl ID : ENSOMEG00000004682
Gene Symbol: RPS7
3 Cross references
357 Possible Orthologues:

Ribosomal Protein S9

Ensembl ID : ENSOMEG00000010547
Gene Symbol: RPS9
3 Cross references
235 Possible Orthologues:

Ribosomal Protein Sa

Ensembl ID : ENSOMEG00000009576
Gene Symbol: RPSA
4 Cross references
515 Possible Orthologues:

Selectin E

Ensembl ID : ENSOMEG00000007531
Gene Symbol: SELE
1 Cross references
196 Possible Orthologues:

Serine/threonine-Protein Kinase Pim-1-Like

Ensembl ID : ENSOMEG00000012860
Gene Symbol: LOC112159694
3 Cross references
246 Possible Orthologues:

Serpin Family C Member 1

Ensembl ID : ENSOMEG00000006990
Gene Symbol: SERPINC1
3 Cross references
199 Possible Orthologues:

Serum Amyloid P-Component-Like

Ensembl ID : ENSOMEG00000003548
Gene Symbol: LOC112144002
2 Cross references
400 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSOMEG00000008714
Gene Symbol: SMO
3 Cross references
204 Possible Orthologues:

Sodium Channel, Voltage Gated, Type V-Like, Alpha B

Ensembl ID : ENSOMEG00000021377
Gene Symbol: SCN5LAB
1 Cross references
256 Possible Orthologues:

Sodium Channel, Voltage Gated, Type Xii, Alpha A

Ensembl ID : ENSOMEG00000011796
Gene Symbol: SCN12AA
1 Cross references
248 Possible Orthologues:

Sodium Voltage-Gated Channel Alpha Subunit 4

Ensembl ID : ENSOMEG00000015551
Gene Symbol: SCN4A
1 Cross references
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).